Intermittent fasting has usually required extra caution in type 1 diabetes — a small trial is challenging researchers to look again
Skipping breakfast can be a lifestyle choice for many people. For someone with type 1 diabetes who depends on insulin, changing when food arrives can alter a carefully managed balance between glucose, meals and medication.
That is why a new randomized trial of time-restricted eating in adults with type 1 diabetes and overweight or obesity is notable. Thirty-two participants were assigned to an eight-hour eating window, daily calorie restriction or no dietary intervention for six months.
The time-restricted group improved HbA1c compared with the calorie-restriction group and did not experience more severe hypoglycemia, hyperglycemia or diabetic ketoacidosis. But this was a very small, supervised trial — not permission to experiment with fasting without medical guidance.
Fasting is different when insulin is essential
In type 1 diabetes, the pancreas produces little or no insulin. People therefore need insulin even when they are not eating, and doses must be balanced against food, activity, illness and other factors.
Too much insulin relative to available glucose can cause dangerous hypoglycemia. Too little can lead to severe hyperglycemia and, in some circumstances, diabetic ketoacidosis. Restricting eating times can change insulin needs in ways that require planning.
For type 1 diabetes, fasting is not simply a matter of willpower or meal timing; it is a medication-management problem as well.
The trial tested an eight-hour eating window
In the Diabetes Care trial, adults were randomized to eat between noon and 8 p.m. without counting calories, reduce daily calories by 25%, or continue usual eating. The study lasted six months.
Body weight did not fall significantly more with time-restricted eating than with calorie restriction or the control condition. HbA1c, however, was lower in the time-restricted group compared with the calorie-restriction group by about 0.46 percentage points.
The study also illustrates why weight loss and metabolic improvement are not interchangeable. A diet can change glucose patterns without producing a large change on the scale, and the reverse can also occur. For people with type 1 diabetes, researchers are particularly interested in whether an eating strategy can improve glycemic control without increasing episodes at either dangerous extreme.
The trial’s most interesting signal was glucose control, not dramatic weight loss.
The safety result is encouraging — and easy to overread
Researchers reported no increase in diabetic ketoacidosis, severe hypoglycemia or severe hyperglycemia in the time-restricted group. That is reassuring because those are among the major concerns when meal patterns change in insulin-treated diabetes.
Save this article
Enter your email address and we'll send it straight to your inbox.
But 32 participants are far too few to rule out uncommon harms. Trial volunteers also receive monitoring and instructions that someone following a social-media fasting plan may not have.
“No increase in serious events in a small trial” is very different from “fasting is proven safe for everyone with type 1 diabetes.”
This does not replace individualized diabetes care
People use different insulin regimens, pumps, continuous glucose monitors and automated insulin-delivery systems. Exercise schedules, pregnancy, kidney disease, history of severe hypoglycemia and other factors can radically change the risk of fasting.
Anyone with type 1 diabetes interested in time-restricted eating should discuss it with their diabetes team rather than simply compressing meals and hoping the existing insulin plan still fits.
The more tightly a diet interacts with a life-sustaining medication, the less appropriate a one-size-fits-all eating rule becomes.
Final word
Time-restricted eating has become so mainstream that it can sound like a harmless scheduling trick. This trial is valuable precisely because it tested the idea in a group for whom changing meal timing has higher stakes.
The early results justify larger studies, especially to understand safety, sustainability and which patients might benefit. They do not establish time-restricted eating as standard treatment for type 1 diabetes.
The study opens a door researchers had been cautious about entering; it does not remove the need for medical supervision on the other side.
